Try our beta test site

Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2017 by Washington University School of Medicine
Sponsor:
Information provided by (Responsible Party):
Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT01670877
First received: August 17, 2012
Last updated: February 8, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 30, 2020
  Estimated Primary Completion Date: December 31, 2018 (Final data collection date for primary outcome measure)